These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9798476

  • 1. [Role of anaerobic bacteria in community-acquired respiratory pathology].
    Dubreuil L.
    Presse Med; 1998 Sep; 27 Suppl 4():10-1. PubMed ID: 9798476
    [No Abstract] [Full Text] [Related]

  • 2. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
    Poirier R.
    Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
    [No Abstract] [Full Text] [Related]

  • 3. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the microbiologist].
    Quentin C.
    Presse Med; 1998 Sep; 27 Suppl 4():12-3. PubMed ID: 9798477
    [No Abstract] [Full Text] [Related]

  • 4. [Experimental and clinical study of the effect of antibiotics, oxytocin and their combinations on resistance of pathogens causing acute suppurative-inflammatory diseases of lungs and pleura].
    Abramzon OM, Kartashova OL, Valyshev AV, Kirillov DA, Perunova NB, Elagina NN, Valysheva IV, Bukharin OV.
    Antibiot Khimioter; 2003 Sep; 48(12):14-7. PubMed ID: 15176098
    [No Abstract] [Full Text] [Related]

  • 5. Chapter 2-1. Anaerobic infections (individual fields): respiratory infections.
    Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, Japanese Association for Anaerobic Infection Research.
    J Infect Chemother; 2011 Jul; 17 Suppl 1():42-6. PubMed ID: 21728090
    [No Abstract] [Full Text] [Related]

  • 6. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B, Carratalà J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F.
    Microb Drug Resist; 2001 Jul; 7(1):85-96. PubMed ID: 11310807
    [Abstract] [Full Text] [Related]

  • 7. [Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
    Caputi M, Guarino C, Cautiero V, Sorrentino L, Cione P, Cuccurullo S, Tarantino C.
    Arch Monaldi Mal Torace; 1990 Jul; 45(5):401-10. PubMed ID: 2152338
    [Abstract] [Full Text] [Related]

  • 8. First case of pleural empyema and pulmonary abscess caused by Eggerthia catenaformis.
    Duport P, Miltgen G, Kebbabi C, Belmonte O, Coolen-Allou N, Allyn J, Allou N.
    Anaerobe; 2018 Apr; 50():9-11. PubMed ID: 29371096
    [Abstract] [Full Text] [Related]

  • 9. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
    File TM.
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
    [Abstract] [Full Text] [Related]

  • 10. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 11. [Antibacterial preparations against nonsporulating anaerobic bacteria].
    Oleĭnik II, Bychenko BD, Robustova TG, Zhdanov LP.
    Antibiotiki; 1984 Aug; 29(8):619-28. PubMed ID: 6385833
    [No Abstract] [Full Text] [Related]

  • 12. Anaerobic pulmonary infections in children.
    Brook I.
    Pediatr Emerg Care; 2004 Sep; 20(9):636-40. PubMed ID: 15599270
    [Abstract] [Full Text] [Related]

  • 13. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
    Yakovlev SV, Suvorova MP.
    Antibiot Khimioter; 1997 Sep; 42(10):23-8. PubMed ID: 9412399
    [No Abstract] [Full Text] [Related]

  • 14. Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
    Lieberman D, Schlaeffer F.
    J Antimicrob Chemother; 1995 Feb; 35(2):354-7. PubMed ID: 7759403
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of anaerobic pulmonary infections.
    Bartlett JG.
    J Antimicrob Chemother; 1989 Dec; 24(6):836-40. PubMed ID: 2695509
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of respiratory tract infections with augmentin.
    Cioffi R, Turco D, Alfano B, Di Salvatore F, Gnasso P, Mastroianni S.
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract] [Full Text] [Related]

  • 17. [Anaerobic nonsporulating infection in lung and pleural diseases].
    Ivchenko VN, Mel'nik VM, Bil'ko IP, Mil'chenko KP, Tyshko AG.
    Klin Khir (1962); 1983 Oct; (10):9-13. PubMed ID: 6656135
    [No Abstract] [Full Text] [Related]

  • 18. [Incidence of anaerobic bacteria in respiratory tract infections].
    Kedzia A, Kwapisz E, Wierzbowska M.
    Pneumonol Alergol Pol; 2003 Oct; 71(1-2):68-73. PubMed ID: 12959026
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of non tuberculous respiratory tract infections].
    Cicero R.
    Prensa Med Mex; 1969 Oct; 34(5):Suppl:84-93. PubMed ID: 5380779
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.
    Fernández-Sabé N, Carratalà J, Dorca J, Rosón B, Tubau F, Manresa F, Gudiol F.
    Eur J Clin Microbiol Infect Dis; 2003 Mar; 22(3):185-7. PubMed ID: 12649717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.